B1NT34 trade ideas
potential bull run to the Q3 earningsThe news are great, the fundamentals better than ever, but the stock is dropping.
WHY?
The big reason is, that big money wants to buy your share before the next bull run.
Therefore they try to push the price into liquidity zones where a lot of Stop/Losses are triggered.
250€ and 200€ are important Fibonacci targets which act like magnets.
Bull Case:
These are the current support zones.
If we assume that we have a finished Elliott Wave, than 250€ could be a support with the 0.618 Fibonacci Retracment.
This is the current Elliott Wave count, eventhough it's not quite perfect. Ignoring some minor flaws, it's still intact.
If we do a normal extention than we could have a first target nearby 600€ (700$) and 800€ (903$) for the long term.
(bear in mind that there could be an overthrow due to the hype in a parabolic movement)
Are 600€ even possible?
Fundamentally, Yes. Technically, Yes.
We had a 144% gain on the last run to the Q2 earnings which we need now for a 600€ target.
What are the risk?
If the Elliott Wave isn't correct, than we could drop even further to the bigger correction nearby 200€.
The current sentiment is extremely cautious due to the Evergrand situation. It's all about timing now if we hit the perfekt window.
PS: I'm just drawing lines. These charts are extremely speculativ. Do your own due dilligence!
BNTX212 day above 269.42 week 2up already triggered also sitting at a historical level of support/res
BNTX SHORT SWING TRADE | BNTX | SHORT @ 340 - 336 | TP @ 332, 328, 324, 320, 316 | SL @ 356 | PATTERN = N/A |
PNF chart on the hourly shows a trend reversal.
The strategies I use involve a mix of PNF and Renko. My type of trading is strictly swing trading.
Strong Long 500 Zig Zag Target ReachedStrong Long 500 Zig Zag Target Reached
Take. BUY it very fast ... 21000
BNTXI am Bullish on BNTX.
Put it in your watchlist.
BioNTech SE is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases.
Long | BNTX | Swing TradeNASDAQ:BNTX
Possible Scenario: LONG
Evidence: Price Action,
TP1: 360$
TP2: 377$
Call options, strike 360$, 11/19/2021.
Call options, strike 365$, 09/17/2021.
*This is my idea and could be wrong 100%.
Looks like we are good for a next runWell, i expected a deeper correction but the news flowing around are too good for both BNTX and MRNA and it hasn't taken a deep dive i expected. In fact, i see BNTX doing another run up now with the start of this Wave. I will post the MRNA chart as well.
PS. i did loose some money on MRNA shorts in the last few weeks. Planning to go long soon again on these.
BNTX Daily TimeframeSNIPER STRATEGY
This magical strategy works like a clock on almost any charts
Although I have to say it can’t predict pullbacks, so I do not suggest this strategy for leverage trading.
It will not give you the whole wave like any other strategy out there but it will give you huge part of the wave.
The best timeframe for this strategy is Daily, Weekly and Monthly however it can work any timeframe above three minutes.
Start believing in this strategy because it will reward believers with huge profit.
There is a lot more about this strategy.
It can predict and also it can give you almost exact buy or sell time on the spot.
I am developing it even more so stay tuned and start to follow me for more signals and forecasts.
BNTX - HTF Candidate w/ R/R Favorability - (9/12/2021)MA have caught up in this name which offers a good entry point that is not overextended. Stock has made 2 100% run ups after a consolidation pattern. If we look at volume in the last run up there was more volume than the previous run which indicates inst. support. Will manage risk at the lows of Thursday which is about a 3.7% risk where the upside potential is the previous peak or 31%. ATR is also declining which is a positive signal.
Market breath overall is worsening which makes me cautious moving into next week. Will have tight risk through next week and be taking minimal new positions until the market tells me we are back in a uptrend.
BNTX ShortNASDAQ:BNTX
Hey guys,
This is my first analysis so please do not be too harsh on me.
After several months of exceptional performance, I do believe that the Biontech stock reached its peak on 10-08-2021 (450$).
The vaccinations are still going on and a lot of people opt for the Fizer/Biontech vaccine with certainly has its impact on the stock market.
I have little to no experience in Fundamentals, so I choose the technical path.
Looking at the Chart (4H Timeframe) you can see with the Ichimoku cloud (settings: 20, 60, 120, 30), RSI (14), DMI (14, 14), and the Volume that the upwards trend is slowly starting to subside.
Even without indicators, this fade is pretty obvious.
Looking at the Ichimoku cloud the price broke the cloud and seems to move down. This theory is supported by the fact that a crossing between the Conversion Line and the Base Line.
The DMI Indicator saw this trend reversal a week earlier so this is also a confirmation sign.
Furthermore, we can observe that the RSI broke below the "50" line and is moving dangerously close to the oversold section.
Now since this is still an upwards trend, with the price still above the 200 MA with addition to trend lines,
it is difficult to say if this move right now is a trend reversal or just a correction for the overbought timespan end Juli till mid-August.
Taking in the Fib-Retracements into account for this setup the most likely scenario would be that the price retests the Ichimoku cloud and moves to the 0.618 retracement.
So the setup would be:
Entry: 324€
Stop loss: 330€ (above the Leading Span B/ red line from the cloud but below the green line Span A)
Take profit: 301€ (above 300€ natural horizontal support/resistance)
Hope this analysis helps you with the decision :)
Happy trading
Ocamond
BNTX is ready to fly soonI am anticipating a new ATH very soon as you can see it is consolidating for a longer run.
looking for sell #BioNTech SE is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases.
Covid-19 vaccine maker BioNTech plans to make any malaria or tuberculosis vaccine it develops in Africa, the company said on Friday.
The announcement comes at a time when debate is growing over the moral obligation of richer countries to share Covid-19 vaccines with poorer ones—particularly the messenger RNA-based vaccines developed by BioNTech (ticker: BNTX), its partner, Pfizer (PFE), and their competitor, Moderna
Biontech with a short-term target of 415$ ~ 350€After the last ATH, Biontech corrected quite swiftly with up to -31% on the swing low.
Let's analyze where we are going most likely to trend next:
First look at the bigger scope:
Lower time frame:
Wave analysis:
Targets:
What will happen afterwards?
$BNTX Long term PT 950 and higher$BNTX Leaps Calls 680 Mar 17th 2023 Returns +403%
The FDA approval of Pfizer’s COVID-19 vaccine is a ‘critical step forward in vaccine confidence’: Doctor
BNTX original breakout Trades that will make you money. The BNTX charts gave us a beautiful tight range and BOOM! Made two moves from flags - 100% each.
time to buy bntxit's time to buy bntx because it's dropped to a lot in a short time so it will go up approximated as before
Gap Down, Double Bottomwell, didn't give any opportunity to short it. Opened up with a Gap down, made a double bottom and reversed. We are in Wave B now.
Plan for tomorrowWe probably are going to see another dip from here to take it down to $300. If it stay below the channel, i will look for opportunities to short.
Great company but highly overrated stock priceBioNTech was a nobody until they made in just one weekend THE mRNA vaccine everyone spoke about for almost a year.
They have some big brains out there and they have huge potential but right now, it's just the potential because they aren't really producing the vaccine, Pfizer does it because they have the proper facilities and logistics this vaccine requires.
Sorry NASDAQ:BNTX but you need a reality check and I'm sure it will happen after the quarterly report on Monday. $84B company. Like... REALY?!
Buckle up!
Targets for next few daysWe are still in Wave A and completing Sub Wave 3. Expect a choppy upmove for few hours for Wave 4 followed by another leg down. I think 330 could be a reasonable target for this wave A
